CN1086290C - 治疗尖锐湿疣的组合物 - Google Patents

治疗尖锐湿疣的组合物 Download PDF

Info

Publication number
CN1086290C
CN1086290C CN97122670A CN97122670A CN1086290C CN 1086290 C CN1086290 C CN 1086290C CN 97122670 A CN97122670 A CN 97122670A CN 97122670 A CN97122670 A CN 97122670A CN 1086290 C CN1086290 C CN 1086290C
Authority
CN
China
Prior art keywords
composition
condyloma acuminatum
infection
catechin
condyloma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CN97122670A
Other languages
English (en)
Chinese (zh)
Other versions
CN1185947A (zh
Inventor
程书钧
王德昌
原征彦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nitto Food Co ltd
Mitsui Norin Co Ltd
Original Assignee
Cancer Hospital and Institute of CAMS and PUMC
Mitsui Norin Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Hospital and Institute of CAMS and PUMC, Mitsui Norin Co Ltd filed Critical Cancer Hospital and Institute of CAMS and PUMC
Publication of CN1185947A publication Critical patent/CN1185947A/zh
Application granted granted Critical
Publication of CN1086290C publication Critical patent/CN1086290C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pyrane Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Epoxy Compounds (AREA)
CN97122670A 1996-11-18 1997-11-17 治疗尖锐湿疣的组合物 Expired - Lifetime CN1086290C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP321195/96 1996-11-18
JP32119596A JP3213557B2 (ja) 1996-11-18 1996-11-18 茶カテキンを有効成分として含有する尖圭コンジローマ治療剤

Publications (2)

Publication Number Publication Date
CN1185947A CN1185947A (zh) 1998-07-01
CN1086290C true CN1086290C (zh) 2002-06-19

Family

ID=18129859

Family Applications (1)

Application Number Title Priority Date Filing Date
CN97122670A Expired - Lifetime CN1086290C (zh) 1996-11-18 1997-11-17 治疗尖锐湿疣的组合物

Country Status (13)

Country Link
US (1) US5795911A (enExample)
EP (1) EP0842660B1 (enExample)
JP (1) JP3213557B2 (enExample)
KR (1) KR100312252B1 (enExample)
CN (1) CN1086290C (enExample)
AT (1) ATE288266T1 (enExample)
AU (1) AU716120B2 (enExample)
CA (1) CA2221370C (enExample)
DE (2) DE69732402T2 (enExample)
ES (1) ES2232849T3 (enExample)
FR (1) FR12C0077I2 (enExample)
PT (1) PT842660E (enExample)
TW (1) TW371628B (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100337690C (zh) * 2005-02-07 2007-09-19 上海复旦张江生物医药股份有限公司 一种评价治疗尖锐湿疣药物有效性的方法
CN107530321A (zh) * 2015-03-19 2018-01-02 温迪·安妮·爱泼斯坦 针对女性性障碍的治疗化合物和治疗形式

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6197808B1 (en) * 1996-11-18 2001-03-06 Cancer Instititute (Hospital), Chinese Academy Of Medical Sciences Methods for treating hyperplasia
US5968973A (en) * 1996-11-18 1999-10-19 Cancer Institute (Hospital), Chinese Academy Of Medical Sciences Method for treating hyperplasia
WO1999016319A1 (en) 1997-09-29 1999-04-08 China Innovation Center For Life Science (Usa) A fagopyrum cymosum (trev.) meisn composition, method to prepare and analyze the same and uses thereof
CN1063957C (zh) 1997-09-29 2001-04-04 北京华颐中药制药厂 一种金荞麦制剂的制备方法
EP0938897A1 (en) * 1997-12-26 1999-09-01 Japanese Foundation For Cancer Research Telomerase inhibitor
US6030622A (en) * 1998-06-23 2000-02-29 Shehadeh; Ahmad Abdallah Herbal extract composition and method with immune-boosting capability
EP1100496A4 (en) * 1998-07-21 2002-10-23 Univ Jefferson SMALL PROTEIN INHIBITOR MOLECULES BCL-2
KR100319973B1 (ko) * 1998-12-05 2002-04-22 이인수 녹차카테킨을 유효성분으로 하는 자궁경부 상피내종양 예방 또는 치료제 조성물
ATE466577T1 (de) 2001-05-03 2010-05-15 Cornell Res Foundation Inc Behandlung von krankheiten, die durch hpv verursacht werden
DE10156794B4 (de) 2001-11-19 2006-05-18 Medigene Ag Arzneimittel zur Behandlung von Warzen
US7858662B2 (en) * 2001-11-19 2010-12-28 Medigene Ag Medicament for the treatment of viral skin and tumour diseases
US7972632B2 (en) 2003-02-28 2011-07-05 Unigen Pharmaceuticals, Inc. Identification of Free-B-Ring flavonoids as potent COX-2 inhibitors
US7108868B2 (en) 2002-03-22 2006-09-19 Unigen Pharmaceuticals, Inc. Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia
US8945518B2 (en) * 2002-04-30 2015-02-03 Unigen, Inc. Formulation of dual eicosanoid system and cytokine system inhibitors for use in the prevention and treatment of oral diseases and conditions
US8034387B2 (en) 2002-04-30 2011-10-11 Unigen, Inc. Formulation of a mixture of free-B-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments
NZ535988A (en) * 2002-04-30 2005-09-30 Unigen Pharmaceuticals Inc Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent
US7780992B2 (en) 2002-12-08 2010-08-24 Tareq Abduljalil Albahri Antiviral medicament
AU2004228021B2 (en) * 2003-04-04 2010-09-02 Unigen, Inc. Formulation of dual cycloxygenase (COX) and lipoxygenase (LOX) inhibitors for mammal skin care
US7763588B2 (en) * 2003-06-13 2010-07-27 The Salk Institute For Biological Studies Method for increasing cognitive function and neurogenesis
CN1845750B (zh) * 2003-09-02 2014-05-07 尤尼根公司 用于预防及治疗认知衰退和年龄相关的记忆障碍的无取代b环类黄酮和黄烷混合物的组合物
US20050079235A1 (en) * 2003-10-09 2005-04-14 Eggert Stockfleth Use of a polyphenol for the treatment of actinic keratosis
BRPI0415215B8 (pt) 2003-10-09 2021-05-25 Medigene Ag uso de polifenol na preparação de medicamento
US20070082073A1 (en) * 2005-05-18 2007-04-12 University Of South Florida Catechin Adjuvants
US8044098B2 (en) * 2005-08-02 2011-10-25 Shenghua Guangzhou Pharmaceutical Science & Technology Co., Ltd. Use of hydroxybenzoic acids and their esters and analogues for preventing or treating virus infection
KR100801891B1 (ko) 2006-11-02 2008-02-12 한상진 천연물질을 이용한 생식기 염증 예방 또는 치료용 약제학적 조성물
EP2179722A1 (en) 2008-10-24 2010-04-28 Heinrich-Pette-Institut für experimentelle Virologie und Immunologie Topical formation for preventing sexual transmission of viral infection
ES2349966B1 (es) * 2008-10-30 2011-11-18 Ignacio Umbert Millet Formulaciones topicas para el tratamiento de verrugas.
US20110218241A1 (en) * 2010-03-06 2011-09-08 Cacao Bio-Technologies, Llc Antiviral epicatechins, epicatechin oligomers, or thiolated epicatechins from theobroma cacao for treatment of genital warts
WO2012100835A1 (en) 2011-01-28 2012-08-02 Laboratorios Del Dr. Esteve, S.A. Methods and compositions for the treatment of aids
WO2014110284A1 (en) 2013-01-09 2014-07-17 Bacterin International, Inc. Bone graft substitute containing a temporary contrast agent and a method of generating such and a method of use thereof
MX367243B (es) * 2016-02-04 2019-08-09 Maria Del Carmen Ramirez Olvera COMPOSICIÓN DE EXTRACTOS DE PLANTAS QUE INCREMENTAN LOS BACILOS DE DöDERLEIN, USADA PARA EL TRATAMIENTO DE ENFERMEDADES DE TRANSMISIÓN SEXUAL (ETS) Y DEL VIRUS DEL PAPILOMA HUMANO (VPH), CON EFECTO AFRODISIACO.
CN106727275A (zh) * 2016-12-15 2017-05-31 珠海聚焦先导生物研究院有限公司 一种治疗阴道炎的栓剂组合物
CN107349197A (zh) * 2017-07-13 2017-11-17 黄冈师范学院 一种儿茶素在制备治疗皮肤乳头状瘤的药物上的应用
IT202200013867A1 (it) * 2022-06-30 2023-12-30 Lo Li Pharma Srl Composizione per il trattamento dell’ infezione da papilloma virus (hpv)
US12111395B2 (en) * 2023-01-30 2024-10-08 Semiconductor Components Industries, Llc Acoustic sensing of proximate obstacles
WO2025227040A1 (en) * 2024-04-26 2025-10-30 Amplexd Therapeutics, Inc. Pharmaceutical compositions and methods for treatment of intraepithelial dysplasia and neoplasia

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2128207B1 (enExample) * 1971-03-11 1974-08-02 Zyma Sa
US5159069A (en) * 1988-12-20 1992-10-27 Yamanouchi Pharmaceutical Co., Ltd. Sulfated tannins and their salts
JP2727471B2 (ja) * 1989-09-14 1998-03-11 三井農林株式会社 インフルエンザウィルス感染予防剤
JPH03141220A (ja) * 1989-10-26 1991-06-17 Tsumura & Co 抗レトロウイルス剤
JP3019996B2 (ja) * 1990-03-01 2000-03-15 三井農林株式会社 白癬治療剤
US5211944A (en) * 1990-10-12 1993-05-18 Shaman Pharmaceuticals, Inc. Proanthocyanidin polymers having antiviral activity and methods of obtaining same
DE4211238C2 (de) * 1992-04-03 1994-10-27 Edward I Budowskij Verwendung von 2',5'-Oligoadenylaten zur Behandlung von Papillomatosen
US5605929A (en) * 1992-05-27 1997-02-25 Arch Development Corp. Methods and compositions for inhibiting 5α-reductase activity
US5648377A (en) * 1993-12-21 1997-07-15 Indena S.P.A. Formulations containing carotenoids an procarotenoids combined with polyphenols in the prevention of the damages due to an abnormal production of free radicals
GB2293548A (en) * 1994-09-29 1996-04-03 Joan Louise Hibberd Treatment of herpes infections
IT1275905B1 (it) * 1995-03-14 1997-10-24 Indena Spa Frazioni polifenoliche di te', loro uso e formulazioni che le contengono
US5576013A (en) * 1995-03-21 1996-11-19 Eastern Virginia Medical School Treating vascular and neoplastic tissues
JPH1036260A (ja) * 1996-07-18 1998-02-10 Mitsui Norin Kk 抗ガン剤の効力増強方法

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CA 116:207381 1991.1.1 ATSUSHI M.INHIBITION OF ROTAVIRUS AND ENTERUS AND ENTEROVIRUS THE INFECTIO *
CA 116:207381 1991.1.1 ATSUSHI M.INHIBITION OF ROTAVIRUS AND ENTERUS AND ENTEROVIRUS THE INFECTIO;CA 120;153052 1993.1.1 MIKIO N.INHIBITION OF THE INFECTIVITY OF INFLUENZA VIRUS BY TEA POLYPHENOL *
CA 120;153052 1993.1.1 MIKIO N.INHIBITION OF THE INFECTIVITY OF INFLUENZA VIRUS BY TEA POLYPHENOL *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100337690C (zh) * 2005-02-07 2007-09-19 上海复旦张江生物医药股份有限公司 一种评价治疗尖锐湿疣药物有效性的方法
CN107530321A (zh) * 2015-03-19 2018-01-02 温迪·安妮·爱泼斯坦 针对女性性障碍的治疗化合物和治疗形式
CN107530321B (zh) * 2015-03-19 2022-12-30 Gto制药有限责任公司 针对女性性障碍的治疗化合物和治疗形式

Also Published As

Publication number Publication date
DE69732402D1 (de) 2005-03-10
CN1185947A (zh) 1998-07-01
ATE288266T1 (de) 2005-02-15
KR19980042555A (ko) 1998-08-17
DE122009000072I1 (de) 2010-03-25
KR100312252B1 (ko) 2002-02-19
CA2221370C (en) 2004-03-02
AU4443897A (en) 1998-06-04
PT842660E (pt) 2005-05-31
EP0842660B1 (en) 2005-02-02
ES2232849T3 (es) 2005-06-01
DE122009000072I2 (de) 2011-07-21
FR12C0077I2 (fr) 2013-08-16
AU716120B2 (en) 2000-02-17
TW371628B (en) 1999-10-11
US5795911A (en) 1998-08-18
FR12C0077I1 (enExample) 2013-02-01
JP3213557B2 (ja) 2001-10-02
JPH10147525A (ja) 1998-06-02
DE69732402T2 (de) 2006-01-19
EP0842660A1 (en) 1998-05-20
CA2221370A1 (en) 1998-05-18

Similar Documents

Publication Publication Date Title
CN1086290C (zh) 治疗尖锐湿疣的组合物
Bachmann et al. Diagnosis and treatment of atrophic vaginitis
Willhite et al. Urogenital atrophy: prevention and treatment
US5968973A (en) Method for treating hyperplasia
Sauerbronn et al. The effects of systemic hormonal replacement therapy on the skin of postmenopausal women
Drake et al. Guidelines of care for warts: human papillomavirus
Manonai et al. The effect of estradiol vaginal tablet and conjugated estrogen cream on urogenital symptoms in postmenopausal women: a comparative study
US6197808B1 (en) Methods for treating hyperplasia
Syed et al. Human leukocyte interferon-alpha versus podophyllotoxin in cream for the treatment of genital warts in males: a placebo-controlled, double-blind, comparative study
MX2008009177A (es) Metodo para tratar vaginitis atrofica.
WO2016037131A1 (en) Secnidazole for use in the treatment of bacterial vaginosis
CN112203656B (zh) 用于治疗宫颈病症的洛匹那韦和利托那韦
WO2000033832A1 (en) Chemical composition for treating cervical intraepithelial neoplasia i, ii, iii, iv and cervicitis
Foldvari et al. Clinical observations with topical liposome-encapsulated interferon alpha for the treatment of genital papillomavirus infections
Hashmi et al. Efficacy of Sphaeranthus indicus and cream of Lawsonia inermis in cervical erosion with cervicitis
US5352699A (en) Use of retinioc acid to treat vaginal atrophy
CN1128633C (zh) 治疗妇科炎症的外用药物
CN115837054B (zh) 一种防治hpv感染和阴道炎的中药组合物、制备方法和应用
CN108619136B (zh) 一种抗hpv的制剂
CN101049329A (zh) 当归油在升高内源性雌二醇水平,用于治疗雌二醇相关性疾病的用途
Mark Medroxyprogesterone acetate as a contraceptive for female drug addicts
EP3897632A1 (en) Composition for the treatment of female sexual dysfunctions
Castelo-Branco et al. Compounds for the treatment of atropic vaginitis
CN119656273A (zh) 一种用于预防和/或治疗炎症性疾病的局部经皮给药的药物组合物及其用途
RU2747987C1 (ru) Композиция для лечения латентной и субклинической папилломавирусной инфекции шейки матки и способ ее применения

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C56 Change in the name or address of the patentee

Owner name: NITTO FOOD CO., LTD.

Free format text: FORMER NAME OR ADDRESS: MITSUI NORIN KK

Owner name: MITSUI NORIN KK

Free format text: FORMER NAME OR ADDRESS: NITTO FOOD CO., LTD.

CP01 Change in the name or title of a patent holder

Patentee after: Nitto Food Co.,Ltd.

Patentee before: Mitsui Norin Co.,Ltd.

Patentee after: Mitsui Norin Co.,Ltd.

Patentee before: Nitto Food Co.,Ltd.

CX01 Expiry of patent term

Granted publication date: 20020619